Abbott Reports Second-Quarter 2022 Results and Raises Full-Y

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022. Second-quarter sales of $11.3 billion...

Related Keywords

China , Robertb Ford , , Linkedin , Drug Administration , Core Laboratory Diagnostics , Sales In Core Laboratory , European Union Medical Device , Facebook , Abbott Laboratories , Core Laboratory , Pediatric Nutrition , Adult Nutrition , Molecular Diagnostics , Emerging Markets , Medical Devices , Diabetes Care , Freestyle Libre , Aristocrats Index , Investor Relations , Private Securities Litigation Reform Act , Caution Concerning Forward Looking , Annual Report , Abbott Diabetes , Consolidated Statement , Quarter Ended June , Operating Cost , Earnings Excluding Specified Items , Common Share , Specified Items , Common Shares , Dilutive Common Stock Options , Diluted Earnings , Half Ended June , Financial Information , Gross Margin , European Union , Medical Device , Vitro Diagnostics Medical Device , Abbott , Household , Onsumer Amp Cosmetics , Retail , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Earnings Forecasts Amp Projections , Earnings ,